Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: is it a problem? A cross-sectional study

M Showell, S Buckman, S Berber, N Ata Allah… - PLoS …, 2023 - journals.plos.org
Background Timely publication of clinical trials is critical to ensure the dissemination and
implementation of high-quality healthcare evidence. This study investigates the publication …

[HTML][HTML] Clinical trial transparency in the Americas: the need to coordinate regulatory spheres

T Lemmens, CH Vacaflor - bmj, 2018 - bmj.com
Clinical trial transparency in the Americas: the need to coordinate regulatory spheres | The BMJ
Skip to main content Intended for healthcare professionals Access provided by Google Indexer …

Transparencia sobre los ensayos clínicos en la Región de las Américas: necesidad de coordinar las esferas regulatorias

T Lemmens, C Herrera Vacaflor - Rev Panam Salud Publica; 43, jun …, 2019 - iris.paho.org
[EXTRACTO]. En su Política de investigación para la salud del 2009, la Organización
Panamericana de la Salud/Organización Mundial de la Salud (OPS/OMS) reiteró el papel …

[PDF][PDF] Transparência nos ensaios clínicos nas Américas: É preciso coordenar as esferas reguladoras

T Lemmens, CH Vacaflor, NA Gallagher, M Eagle… - Américas, 2019 - researchgate.net
Na sua Política de Pes-quisa para a Saúde de 2009, a Organização Pan-Americana da
Saúde/Organização Mundial da Saúde (OPAS/OMS) reiterou o papel fundamental da …

Ethical considerations in conducting clinical trials

S Mousavinejad, S Bazmi… - … Journal of Medical …, 2021 - research.monash.edu
Background: Clinical trials are the golden key in medical science research with human
participants. They have always been considered interesting topics by researchers and …

[PDF][PDF] Ethical Considerations in Conducting Clinical Trials

M Sh, B Sh, M Rezaei-Taviran… - … Journal of Medical …, 2021 - journals.sbmu.ac.ir
Background: Clinical trials are the golden key in medical science research with human
participants. They have always been considered interesting topics by researchers and …

Opinions and potential solutions regarding dissemination bias from funding agencies of biomedical research in Europe

H Pardo‐Hernandez, G Urrútia… - Journal of evaluation …, 2018 - Wiley Online Library
Rationale, aims, and objectives Several studies have found that about half of research
results from clinical trials are never published. Until now, there has been little information on …

The Declaration of Helsinki and Transparency

T Lemmens, G Ringkamp - … : The Declaration of Helsinki, and the …, 2020 - books.google.com
In recent decades, a growing number of international organizations, national governments,
research funding agencies, civil society groups, researchers, and even pharmaceutical …

[PDF][PDF] Ο νέος Ευρωπαϊκός Κανονισμός 536/2014 για τις κλινικές δοκιμές

Ε Χαλκιαδάκη, Π Γαλάνης, Δ Λάμνισος - Archives of Hellenic …, 2020 - mail.mednet.gr
Στην Ευρώπη, από το 1980, έχει δοθεί έμφαση ώστε το νομοθετικό και το κανονιστικό πλαίσιο
ανάμεσα στα κράτη-μέλη της Κοινότητας να εναρμονιστεί, με σκοπό τη διευκόλυνση της …

[PDF][PDF] Transparencia sobre los ensayos clínicos en la Región de las Américas: necesidad de coordinar las esferas regulatorias

H Vacaflor - researchgate.net
En su Política de investigación para la salud del 2009, la Organización Panamericana de la
Salud/Organización Mundial de la Salud (OPS/OMS) reiteró el papel clave que desempeña …